Analysts said upcoming data on Pfizer's obesity pill, danuglipron, will be crucial to how competitive the company can be against Eli Lilly and Novo Nordisk.
from Business News https://ift.tt/xnCIkMV
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
November 13, 2023
0
